Document Page: First | Prev | Next | All | Image | This Release | Search

File: 123096_sep96_decls23_0025.txt
Page: 0025
Total Pages: 52

Subject: DIAGNOSIS AND TREATMENT OF DISEASES OF IMPORTANCE               

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003203

Folder Title: DIAGNOSIS AND TREATMENT OF DISEASES  1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS                

Document Number:          1

Folder Seq  #:         88










     Complications: the following complications strongly indi-                             G.    "Blackwater Fever:-'
     cate infection with P.      el arum:                                                        1.   Massive hemolysis and hemoglobinuria in the
                                                                                                      setting of P. falciparum malaria is traditionally
     A.   Hyperparasitemia: > 5% of RBC's on smear parasitized;                                       called blac7kwater fever.
          correlates with other complications, though complica-                                  2.   Incidence has decreased with use of modern
          tions can be seen with lower degrees of parasitemia.                                        antimalarials. Its occurrence has been associated
                                                                                                      with quinine use, oxidant antimalarials in G6PD-
     B.   Cerebral malaria:                                                                           deficient patients, or possibly as the result of
          1.    Altered mental status,.personality changes,                                           an atypical immune response. Other causes of
                lethargy, stupor, coma or delirium.                                                   massive hemolysis must be excluded.
          2.    Neurologic impairment: hyperpyrexia, monoplegia,                                 3.   Treatment includes appropriate antimalarials,
                hemiplegia, cerebellar signs, seizures (assess for                                    transfusions and the prevention or management of
                hypoglycemia).                                                                        acute renal failure, including dialysis in some
          3.    Treatment is directed at overall infection,                                           cases.
of value.
          4.    Mortality is high (20-50%) but survivors rarely                       VI. Treatment:
                show neurologic sequelae.                                                  A.    Treatment of choice:
     C.   Algid malaria:                                                                         1.   As chloroquine-resistant cases are not endemic in
          1 .   Clinically resembles septic shock; may be as-                                         this region, initial treatment should be: chloro-
                sociated with hypothemia.                                                             quine phosphate, I gm orally, then 500 mg at 6
          2.    Treatment is directed at overall infection; in-                                       hours, 24 hours and 48 hours.
                travascular volume replacement, vasopressors, and                                2.   Depending on response, prophylaxis can than be
                antibiotics should be added to the antimalarial                                       resumed; or patient can be evacuated, and terminal
                regimen, as needed.                                                                   prophylaxis given if needed.

     D.   Renal Failure@                                                                   B.    Alternatives:
          I .   May be pre-renal or  intrarenal (ATN-like) in                                    I .  Critically ill patients who require IV medication
                origin.                                                                               can receive:
          2.    Treatment:                                                                            a.    Quinidine glucanate, 10 mg/kg (max 600 mg)
                a.   assure adequate  intravascular volume re-                                              loading dose over I to 2 hrs, followed by
nute constant infusion for a
                b.   supportive care  to include dialysis if                                                maximum of 72 hrs. Monitor EKG and switch to
                     needed.                                                                                oral agents when mental status clears and
                                                                                                            parasitemia < 1%.
     E.   Adult respiratory  distress syndrome (ARDS; non-cardio-                                     b.    Quinidine gluconate, 15 mg/kg (max 650 kg)
          genic pulmonary edema):                                                                           loading dose over 4 hours; followed by 7.5
          1.    Pathogenesis: due to increased capillary per-                                               mg/kg over 4 hours QBh for 7 days. Monitor
                meability and fluid extravasation. Avoiding                                                 EKG and switch to oral agents as above.
                excessive intravascular fluid administration may                                      C.    Quinine dihydrochloride, 650 mg IV, over 4
                reduce incidence.                                                                           hours, Q8h for 7 days. switch to oral agents
          2.    Treatment is supportive, to include mechanical                                              as above.
                ventilation.                                                               C.    Treatment  failures or early recrudescence:
     F.   Splenic rupture/hemorrhage:                                                            1.   IV regimen of quinine or quinidine as above, or
          I-    Treatment is blood replacement and control of                                    2.   Quinine sulfate, 650 mg TID for 3 days, orally,
ne-sulfadoxine (Fansidar)
                                                                                                      3 tablets in one dose; or tetracycline, 250 mg QID
                                                                                                      for 7 days; or clindamycin, 900 mg TID for 3 days,
                                                                                                      or


                                 40                                                                                    41

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 52 f:/Week-36/BX003203/DIAGNOSIS AND TREATMENT OF DISEASES 1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS/diagnosis and treatment of diseases of importanc:12179609281524
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = DIAGNOSIS AND TREATMENT OF DISEASES 1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS
Folder Seq # = 88
Subject = DIAGNOSIS AND TREATMENT OF DISEASES OF IMPORTANC
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996